Renal effects of Sacubitril/Valsartan in heart failure with reduced ejection fraction: a real life 1-year follow-up study
Author:
Publisher
Springer Science and Business Media LLC
Subject
Emergency Medicine,Internal Medicine
Link
http://link.springer.com/content/pdf/10.1007/s11739-019-02111-6.pdf
Reference50 articles.
1. Vos T, Barber RM, Bell B et al (2015) Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 386(9995):743–800
2. Ceia F, Fonseca C, Mota T et al (2002) Prevalence of chronic heart failure in Southwestern Europe: the EPICA study. Eur J Heart Fail 4:531–539
3. Belfiore A, Palmieri VO, Di Gennaro C et al (2019) Long-term management of chronic heart failure patients in internal medicine. Intern Emerg Med. https://doi.org/10.1007/s11739-019-02024-4 . (Epub ahead of print)
4. Mozaffarian D, Benjamin EJ, Go AS et al (2016) Heart Disease and stroke statistics-2016 update: a report from the American Heart Association. Circulation 133(15):e599
5. Sarzani R, Bordicchia M, Spannella F et al (2014) Hypertensive heart disease and obesity: a complex interaction between hemodynamic and not hemodynamic factors. High Blood Press Cardiovasc Prev 21(2):81–87
Cited by 44 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Sacubitril/Valsartan in Heart Failure with Hypertension Patients: Real-World Experiences on Different Ages, Drug Doses, and Renal Functions;High Blood Pressure & Cardiovascular Prevention;2023-11-18
2. Early Initiation of Sacubitril/Valsartan in Patients With Acute Heart Failure and Renal Dysfunction: An Analysis of the TRANSITION Study;Journal of Cardiac Failure;2023-09
3. Practical Recommendations for the Use of Angiotensin Receptor-Neprilysin Inhibitors (ARNI) in Heart Failure: Insights from Indian Cardiologists;Cardiology and Therapy;2023-06-29
4. Sacubitril/valsartan: research progress of multi-channel therapy for cardiorenal syndrome;Frontiers in Pharmacology;2023-05-05
5. Dose titration of sacubitril/valsartan for heart failure with reduced ejection fraction: a real‐world study;ESC Heart Failure;2023-03-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3